BioCentury
ARTICLE | Clinical News

Supinoxin: Preliminary Phase I data

March 24, 2014 7:00 AM UTC

Preliminary data from an open-label, dose-escalation, U.S. Phase I trial in about 20 patients with advanced or metastatic solid tumors showed that 25, 50 and 100 mg doses of oral Supinoxin given on da...